Prospective G7 Dual Mobility Total Hip PMCF

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

July 1, 2027

Study Completion Date

February 28, 2029

Conditions
Clinical OutcomesFunctional OutcomesRadiological OutcomesSurvivorshipSafety
Interventions
DEVICE

G7 Dual Mobility hip

Total hip arthroplasty and implantation of the G7 device

Trial Locations (6)

23235

Ortho Virginia, Richmond

23666

Tidewater Orthopaedics, Hampton

27599

University of North Carolina, Chapel Hill

87106

New Mexico Orthopaedics, Albuquerque

97239

Oregon Health and Science University, Portland

07302

Jersey City Medical Center, Jersey City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT03308929 - Prospective G7 Dual Mobility Total Hip PMCF | Biotech Hunter | Biotech Hunter